PriceTargets.com logo

Nutex Health - NUTX Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $2.75
  • Forecasted Upside: 1,258.02%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$0.20 As of 09/29/2023 01:00 AM ET
▲ +0.01 (5.19%)

This chart shows the closing price for NUTX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Nutex Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NUTX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NUTX

Analyst Price Target is $2.75
▲ +1,258.02% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Nutex Health in the last 3 months. The average price target is $2.75, with a high forecast of $3.00 and a low forecast of $2.50. The average price target represents a 1,258.02% upside from the last price of $0.20.

This chart shows the closing price for NUTX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 investment analysts is to buy stock in Nutex Health. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/8/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/7/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/5/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/3/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/3/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/2/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/31/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/30/2023

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/29/2023BenchmarkReiterated RatingBuy ➝ Buy$2.50Low
3/9/2023BenchmarkReiterated RatingBuy$3.00Low
2/22/2023Northland SecuritiesInitiated CoverageOutperform$3.00Low
12/23/2022BenchmarkInitiated CoverageBuy$3.00Low
(Data available from 9/30/2018 forward)

News Sentiment Rating

0.40 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
3/4/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2023
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
5/3/2023
  • 3 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/2/2023
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2023
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2023
  • 1 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
8/31/2023
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/30/2023

Current Sentiment

  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Nutex Health logo
Nutex Health Inc. operates as a network of micro-hospitals. It operates through three segments: Hospital, Population Health Management, and Real Estate. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. The Population Health Management segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment leases land and hospital building. It also provides healthcare and facility management services; and healthcare billing, coding, and collection services. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.
Read More

Today's Range

Now: $0.20
Low: $0.19
High: $0.20

50 Day Range

MA: $0.30
Low: $0.19
High: $0.42

52 Week Range

Now: $0.20
Low: $0.18
High: $2.46

Volume

1,379,254 shs

Average Volume

2,928,201 shs

Market Capitalization

$134.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.7

Frequently Asked Questions

What sell-side analysts currently cover shares of Nutex Health?

The following sell-side analysts have issued reports on Nutex Health in the last twelve months: Benchmark Co., and Northland Securities.
View the latest analyst ratings for NUTX.

What is the current price target for Nutex Health?

2 Wall Street analysts have set twelve-month price targets for Nutex Health in the last year. Their average twelve-month price target is $2.75, suggesting a possible upside of 1,258.0%. Northland Securities has the highest price target set, predicting NUTX will reach $3.00 in the next twelve months. Benchmark Co. has the lowest price target set, forecasting a price of $2.50 for Nutex Health in the next year.
View the latest price targets for NUTX.

What is the current consensus analyst rating for Nutex Health?

Nutex Health currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NUTX will outperform the market and that investors should add to their positions of Nutex Health.
View the latest ratings for NUTX.

What other companies compete with Nutex Health?

Other companies that are similar to Nutex Health include Augmedix, Tabula Rasa HealthCare, American Well, Puma Biotechnology and TScan Therapeutics. Learn More about companies similar to Nutex Health.

How do I contact Nutex Health's investor relations team?

Nutex Health's physical mailing address is 2455 EAST SUNRISE BLVD. SUITE 1204, FORT LAUDERDALE FL, 33304. The company's listed phone number is (713) 660-0557 and its investor relations email address is inve[email protected]. The official website for Nutex Health is www.nutexhealth.com. Learn More about contacing Nutex Health investor relations.